Skip to main content
Livermore
Livermore
ZHEN

Rafferty Asset Management, LLC

SEC CIK
0001389426
Latest filing
Aug 14, 2026

RCKT holding history

Rocket Pharmaceuticals, Inc. in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of RCKT by Rafferty Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−141,212−100.0%Sold outHolders
Q1 2026141,212$505.5K<0.1%+141,212NewHolders
Q2 20250$00.0%−155,875−100.0%Sold outHolders
Q1 2025155,875$1.04M<0.1%−385−0.2%ReducedHolders
Q4 2024156,260$1.96M<0.1%+27,534+21.4%AddedHolders
Q3 2024128,726$2.38M<0.1%+11,081+9.4%AddedHolders
Q2 2024117,645$2.53M<0.1%−211,398−64.2%ReducedHolders
Q1 2024329,043$8.86M<0.1%+120,538+57.8%AddedHolders
Q4 2023208,505$6.25M<0.1%−33,137−13.7%ReducedHolders
Q3 2023241,642$4.95M<0.1%+8,558+3.7%AddedHolders
Q2 2023233,084$4.63M<0.1%−66,375−22.2%ReducedHolders
Q1 2023299,459$5.13M<0.1%+5,498+1.9%AddedHolders
Q4 2022293,961$5.75M<0.1%+67,443+29.8%AddedHolders
Q3 2022226,518$3.62M<0.1%+139,896+161.5%AddedHolders
Q2 202286,622$1.19M<0.1%−78,651−47.6%ReducedHolders
Q1 2022165,273$2.62M<0.1%+20,866+14.4%AddedHolders
Q4 2021144,407$3.15M<0.1%+56,213+63.7%AddedHolders
Q3 202188,194$2.64M<0.1%+31,707+56.1%AddedHolders
Q2 202156,487$2.50M<0.1%−5,646−9.1%ReducedHolders
Q1 202162,133$2.76M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.